EP 3976038 A1 20220406 - HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS
Title (en)
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS
Title (de)
HETEROCYCLISCHE VERBINDUNGEN ALS PRMT5-INHIBITOREN
Title (fr)
COMPOSÉS HÉTÉROCYCLIQUES EN TANT QU'INHIBITEURS DE PRMT5
Publication
Application
Priority
- US 201962854435 P 20190530
- US 202062966337 P 20200127
- US 2020034711 W 20200527
Abstract (en)
[origin: WO2020243178A1] The present disclosure describes novel heterocyclic PRMT5 inhibitors and methods for preparing them. The pharmaceutical compositions comprising such PRMT5 inhibitors and methods of using them for treating cancer, infectious diseases, and other PRMT5 associated disorders are also described.
IPC 8 full level
A61K 31/4725 (2006.01); A61K 31/496 (2006.01); A61K 31/498 (2006.01)
CPC (source: EP KR)
A61K 31/519 (2013.01 - KR); A61K 31/7064 (2013.01 - KR); A61P 31/00 (2017.12 - EP KR); A61P 35/00 (2017.12 - EP KR); C07D 487/04 (2013.01 - EP KR); C07D 519/00 (2013.01 - EP); C07H 19/14 (2013.01 - EP KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020243178 A1 20201203; AU 2020283505 A1 20211223; CA 3141855 A1 20201203; CN 114126614 A 20220301; EP 3976038 A1 20220406; EP 3976038 A4 20230712; JP 2022534998 A 20220804; KR 20220016194 A 20220208
DOCDB simple family (application)
US 2020034711 W 20200527; AU 2020283505 A 20200527; CA 3141855 A 20200527; CN 202080052198 A 20200527; EP 20814821 A 20200527; JP 2021570954 A 20200527; KR 20217043087 A 20200527